• An antagonism between the cardiac actions of quinidine and epinephrine was reported by Mancini and Graubner 1 in 1940. Finnegan and Trounce 2 showed that rhythmic disturbances of the ventricle induced by quinidine in dogs may be reversed by some sympathomimetic amines. More recently, Bobbin et al. 3 and Nickel and Thibaudeau, 4 who used isoproterenol to treat patients with quinidine-induced arrhythmias, made similar observations. Roberts and Baer 5 measured the antagonism between the depressant action of quinidine and the stimulant action of isoproterenol and epinephrine with respect to subatrial rhythmicity in the anesthetized cat, and demonstrated that the effectiveness of quinidine in suppressing ectopic rhythms varies directly with the level of ventricular rhythmicity induced by catecholamines. They suggested that such a relationship may explain why larger doses of quinidine are necessary to prevent the recurrence of eetopic rhythms due to physical and emotional stress in the ambulatory patient than to abolish an attack in the patient confined to bed. 6 The importance of endogenous catecholamines to ventricular rhythmieity was shown by Roberts and Modell 7 and Roberts and Stadter. 8 Using dogs with complete heart block, the former demonstrated that a reduction in catecholamine activity markedly de-creased the idioventricular rate. The latter observed in cats that catecholamine depletion by reserpine diminished the ability of the ventricle to escape from vagal suppression. These observations, as well as those of Roberts and Baer, 5 suggested that the cardiac depressant effect of quinidine was related to the magnitude of adrenergic activity.
An investigation was therefore undertaken to explore the action of quinidine on the atrium and ventricle in unanesthetized dogs in which adrenergic activity was modified by pharmacological or surgical means. Dogs with surgically induced heart block were used because they provided a means of simultaneously assessing the effect of quinidine on atrial and ventricular pacemakers. The results indicate that the ability of quinidine to depress both atrial and ventricular pacemakers is modified by the prevalent sympathetic activity, whereas quinidine-induced arrhythmias are not affected by changes in sympathetic activity.
Methods
All experiments were performed on mongrel dogs, weighing between 8 and 20 Kg., approximately one week after the production of heart block by ligation or by section of the bundle of His. The techniques used to produce heart block and the postoperative care were described in detail by Roberts and Modell. 7 All animals had electrocardiographieally proven, permanent heart block. Adrenalectomy was performed on four of the animals, which thereafter received daily intramuscular doses of cortisone acetate (12.5 to 25 mg.). Bilateral thoracic sympathectomy was performed in two of the adrenaleetomized animals.
The dogs were trained to lie quietly during injections and recording of electrocardiograms. In each animal, the ventricular rate remained remarkably constant from day to day. There was also little variation in control ventricular rate between animals [46 (S.D. = ±9.8) in 20 animals]. Atrial rates, however, tended to show cyclical variations, sometimes as much as 40 beats per minute. *The standard error (S.E.) was not determined when there was less than five dogs in the group. tSee method section for doses and dosage schedules. {Direction of change of rate indicated by arrows; f denotes acceleration while 4 designates slowing. §In all subsequent procedures N-methyl-atropine was administered before quinidine. 11 Average of five animals. **In two of four animals, the atrial rate accelerated, while in the remaining two the atrial rate was decreased.
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In some cases, these appeared to be related to respiration.
The following treatment schedules were used: (1) quinidine alone; (2) quinidine 10 minutes after vagal blockade by N-methyl-atropine (NMA) ; (3) quinidine 10 minutes after ganglionic blockade by hexamethonium (C 6 ) and 20 minutes after NMA; (4) quinidine 10 minutes after NMA in dogs to which reserpine had been given 18 to 24 hours previously; (5) 8 to 10 hours after treatment series no. 4, NMA followed in 10 minutes by C 6 and in 20 minutes by quinidine; (6) quinidine 10 minutes after NMA in animals adrenalectomized 7 days previously; (7) quinidine 10 minutes after C 6 and 20 minutes after NMA in the adrenalectomized animals; (8) quinidine one day after sympathectomy in a previously adrenalectomized animal; (9) quinidine after bilateral vagotomy and spinal transection at Cl. With the exception of treatments nos. 5 and 9, at least one day was permitted to elapse between experiments. As far as possible, each dog was subjected to each of the experiments.
All of the autonomic agents were given by rapid intravenous injection, and with the exception of the quinidine, the solutions of drugs were adjusted so that 0.1 cc./Kg. was injected in each instance. Since doses of 0.2 mg./Kg. of N-methyl-atropine, Circulation Reeearch, Volume XI, October ISO! 2 mg./Kg. of hexamethonium, and 0.1 mg./Kg. of reserpine produced maximal effects, 7 the same doses were used in this study. Quinidine sulfate was injected intravenously during a two-minute interval in doses of 5, 10, and 20 mg./Kg. Solutions were freshly prepared. By dissolving the quinidine in 20 per cent propylene glycol, it was possible to make up a 10 per cent solution and thereby to inject each dose in a volume of less than 3 cc. Injections of comparable amounts of solvent did not affect the heart rate or rhythm. The doses of hexamethonium and reserpine are expressed in terms of free base; the doses of quinidine and N-methyl-atropine are expressed as the salt.
In the reserpinized dogs, bloody diarrhea sometimes provided a special problem. In these animals, and also in the adrenaleetomized animals, blood was examined periodically for electrolyte content, pH, and CO 2 combining power. Fluid and electrolyte therapy was administered as required. The electrolyte and fluid pattern remained grossly normal in all the animals.
Leads I and II of the electrocardiogram were recorded on a Sanborn polygraph. Control records were made during a 30-minute period before a drug was administered. Recordings were made during quinidine injection and every few minutes for the next half hour, and were continued, if necessary, until the rates returned to approximate control level. A 20-second count was taken to be representative of the heart rate. Since maximal effects were usually seen one minute after quinidine, the effects of this agent on atrial and ventricular rates shown in tables 1 and 2 were recorded during this period.
Results
QUINIDINE ALONE
The intravenous injection of quinidine in doses of 5 to 20 mg./Kg. was followed by an immediate acceleration of the ventricle which lasted approximately 2 to 10 minutes (table 1 and fig. 1 ). During recovery, the rate did not usually dip below the control; after recovery, the control rate was maintained. In only one case was there a decrease in the ventricular rate (7 beats per minute). The data also indicate that the ventricular acceleration tended to increase with increasing doses of quinidine.
Quinidine accelerated the atrium in 24 of 33 dogs (table 1) . Acceleration occurred immediately after injection and persisted for approximately 5 to 15 minutes. The atrial rate was occasionally decreased by quinidine. A dose of 5 mg./Kg. produced a slight depression in 3 of 13 dogs, while after the 10 and 20 mg./Kg. doses of quinidine in 6 of 20 animals atrial rates were reduced 5 to 20 beats per minute. In doses of 20 mg./Kg. quinidine often caused convulsions; during these episodes the electrocardiogram could not be continuously monitored, and cardiac rates could not be determined during the peak of quinidine action. For this reason, only 5 and 10 mg./Kg. were used in all but four animals in this study.
QUINIDINE AFTER N-METHYL-ATROPINE (NMA)
NMA did not affect the ventricular rate, nor did it affect the quinidine-induced acceleration (table 1). This observation suggests that the ventricular pacemaker, as previously reported by Roberts and Modell, 7 is not under vagal influence and that ventricular acceleration produced by quinidine is not related to its vagolytic action.
XMA caused acceleration of the atrial rate (table 1) and abolished the cyclical variation in sinus rates. Quinidine nevertheless continued to accelerate the atrium. There was no appreciable change in the incidence of acceleration. This suggests that atrial acceleration by quinidine may be induced by a mechanism other than vagolysis.
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QUINIDINE AFTER PROCEDURES REDUCING ADRENERGIC ACTIVITY
Since acceleration of the atrium and ventricle by quinidine occurred after vagolysis, it was thought that it might be due to an increase in adrenergic activity. Reserpine and hexamethonium, as well as surgical procedures which reduced sympathetic activity, were used to examine this possibility. In these animals, N-methyl-atropine was also administered prior to the injection of quinidine. The data are summarized in tables 1 and 2 and figure 1.
QUIN1DINE AFTER HEXAMETHONIUM (Co)
As previously noted, ventricular and atrial rates were reduced by Ce. 7 After C 6 , an action of quinidine to depress atrial and ventricular pacemakers was unmasked; in 11 of 14 animals, the ventricular and atrial rates were slowed. In six dogs, after 10 mg./Kg., there was an average ventricular rate reduction of 13 beats per minute (from 23 to 10). Only the dose of 5 mg./Kg. of quinidine failed to depress the ventricular rate in all the animals treated. In the three animals in which this dose of quinidine did not depress the rate, it caused an increase of six beats per minute. In the three animals in which atrial rates were not depressed, two were accelerated but only from three to five beats per minute. The effect on the ventricle of 10 mg./Kg. of quinidine was significantly greater (P <0.05) than that of 5 mg./Kg.
QUINIDINE AFTER RESERPINE
Reserpine decreased the atrial and ventricular rates. Like C<s, it also depressed the accelerator action of quinidine on the atrial and ventricular pacemakers. In 6 of 10 animals, quinidine given after reserpine depressed the ventricular rate; it depressed the atrial rate in all dogs.
QUINIDINE AFTER RESERPINE AND C
To reduce adrenergic activity even further and to investigate the effect of quinidine under these conditions, a combination of reserpine and Ce was used. This treatment prevented quinidine acceleration; after quinidine, the slowest atrial and ventricular rates developed. In two of three animals receiving AR-117 VR-7 y.
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FIGURE 1
Effect of quinidine on atrial (AB) and ventricular (VB) rates of dogs with complete heart block after pharmacological reduction of vagal and catecholamine activity. Bates are slioicn above the electrocardiographs tracing (lead II). Tracings B, C, and D were recorded one minute after quinidine (10 mg./Kg.) was administered intravenously, while E was recorded eight minutes after quinidine. The control rates indicated below were recorded just prior to quinidine administration. In C, D, and E, dogs received N-methyl-atropine 10 to 20 minutes before quinidine. A = No drug; B = quinidine alone; C = quinidine 10 minutes after hexa-methonium (control AB 142, Vli 23); D = quinidine 24 hours after reserpine (control AB 131, VB 22); E = quinidine 10 minutes after hexamethonium and 28 hours after reserpine (control AB 125, VB 15). Note occurrence of coupling; coupling interval in 0.66 second.
a dose of 10 mg./Kg. of quinidine, ventricular asystole lasting for at least 20 seconds occurred. One of the three animals did not survive.
QUINIDINE AFTER ADRENALECTOMY
Adrenalectomy did not prevent the acceleration of the atrium and ventricle induced by quinidine; only after C 6 had been administered was the quinidine acceleration pre- vented (table 2) . This observation indicates that cardiac acceleration by quinidine does not require the presence of adrenal medullary tissue.
QUINIDINE AFTER ADRENALECTOMY AND BILATERAL THORACIC SYMPATHECTOMY
The influences of the combination of adrenalectomy and bilateral thoracic sympathectomy on the quinidine action resembles the influence of adrenalectomy and C 6 and Ce with reserpine on quinidine action. Thus, sympathectomy and adrenalectomy prevented the acceleration of atrial and ventricular rates by quinidine (table 2) . Similar results were obtained with quinidine after spinal transection at Cl.
OTHER EFFECTS OF QUINIDINE
In 41 of 85 experiments, regardless of other treatment, coupled beats occurred after quinidine. They were more frequently seen and lasted for a longer period of time after 10 mg./Kg. than after 5 mg./Kg. (table 3) . After vagolysis and suppression of adrenergic activity, quinidine continued to induce coupling ( fig. IB) . There appeared to be a general tendency, however, for the coupling interval to be somewhat longer after sympatholysis regardless of how it was produced. In 9 of 41 experiments, regardless of pretreatment, tripling and runs of ventricular tachycardia occurred after quinidine. In only 2 of 85 experiments did an atrial arrhythmia appear after quinidine (in both eases it was atrial flutter).
In four animals, a dose of 20 mg./Kg. of quinidine prolonged the QRS time from 0.06 to' 0.08 second; after smaller doses, it was unaffected.
The effect of quinidine on blood pressure was examined in two anesthetized dogs (pentobarbital sodium, 30 mg./Kg. intravenously) in which heart block had been induced shortly before the injection of quinidine. In these animals, 10 mg./Kg. of quinidine reduced the blood pressure to approximately 50 per cent of the control level.
Discussion
Our results indicate that the action oi quinidine to depress atrial and ventricular rhythmicity is modified by adrenergie activity. Quinidine depressed the atrial and ventricular rates when sympathetic activity was diminished by surgical or pharmacological means, while it induced acceleration when sympathetic activity was unaltered. The most intense depression of atrial and ventricular rates was produced by quinidine after combined treatment with reserpine and C e . The data also indicate that in the case of the atrium, much the same order of slowing by quinidine results from pretreatment with reserpine and CR, while in the case of the ventricle there is a considerable difference. Following Co, quinidine markedly depressed the ventricular rate but depressed it hardly at all when given after reserpine. Since the degree to which a dose of reserpine may deplete catecholamine varies from animal to animal and even in the same animal is different in atrial and ventricular tissue, 9 the ADRENEROIC AND CAKDIAC ACTIONS OF QUINIDINE 7 6 3 difference in quinidine effects, noted above, may be related to differences iu catecholamine depletion. However, since catecholamine determinations were not made, the differences in quinidine effects cannot be positively correlated with catecholamine content.
The observations also suggest that quinidine causes an increase in adrenergic activity by actions mediated through sympathetic pathways. Catecholamine depletion by reserpine, ganglionic blockade of sympathetic transmission by C 6 , as well as surgical sympatheetomy and spinal transection at Cl, prevented quinidine acceleration. Gold and Modell 10 reported that in unanesthetized dogs, quinidine accelerated the heart when given in doses similar to those used in the present investigation. They suggested that this effect might in part be due to an increase in sympathetic tone reflexly induced as a consequence of an action of quinidine to lower blood pressure. The present study was conducted on unanesthetized animals which, because a long series of daily experiments was planned, could not be subjected to arterial cannulation for the determination of blood pressure. However, the effect of quinidine on blood pressure of dogs with heart block was studied in two anesthetized animals; blood pressure fell sharply after a dose of 10 mg./Kg. In the doses used in the present investigation, quinidine also produced a profound fall in blood pressure of cats. 5 It is possible that quinidine also increased sympathetic activity through a central action, such as that associated with the convulsions seen after 20 mg./Kg.
While sympatholysis prevented the acceleration of the atrium and ventricle by quinidine, it did not depress quinidine-indueed ventricular ectopic rhythms. The only suggestion of such an effect was that the coupling interval was somewhat longer after procedures producing sympatholysis. Hoffman 11 also showed that quinidine may cause arrhythmia in the absence of sympathetic activity. He demonstrated in isolated Purkinje fibers that quinidine in high concentration produced multifocal pacemaker activity. It is probable, therefore, that the development of coupling Circulation Research, Volume XI. October 1962 and ventricular tachycardia after quinidine is not primarily related to sympathetic activity, but is due to direct action on cardiac tissue. However, when adrenergie activity is excessive, the administration of quinidine may induce ventricular ectopic activity in another way. The combination of depression of normal pacemaker (sinoatrial and atrioventricular junction) activity by pharmacological agents and myocardial stimulation by catecholamines has been shown to evoke ectopic ventricular activity. 12 ' 13 It might, therefore, be anticipated that intense sympathetic activity in the presence of quinidineindueed depression of normal pacemaker function may result in development of ectopic ventricular pacemakers.
The fact that sympathetic activity modifies pacemaker depression by quinidine has important clinical implications. Against a background of intense adrenergic activity, the large doses of quinidine required to induce the desired cardiac depression are sometimes also capable of provoking eetopic activity. On the other hand, with low levels of adrenergic activity, small doses of quinidine may be used to depress ectopic foci which are safer because there is less danger of exciting ectopic activity.
Depression of atrial and ventricular rhythrnicity resulted from doses of quinidine which did not significantly prolong QRS time, even when asystole of the ventricle was induced with quinidine after reserpine and Ce-On the other hand, coupling was induced by quinidine, and since this is considered an undesirable effect, the QRS interval is clearly not satisfactory as an overall indicator of quinidine toxieity.
While it is well known that in patients with complete heart block, quinidine may produce ventricular fibrillation, 3 ' 14 it did not cause ventricular fibrillation in the dogs with complete atrioventricular dissociation. Nevertheless, it is possible that had larger doses of quinidine been employed, ventricular conduction would have been slowed, creating a more favorable condition for the development of ventricular fibrillation.
ROBERTS, STADTER, CAIEOLI. MODELL
Summary
Unanesthetized dogs with complete heart block were used to explore the relationship between adrenergic activity and quinidine action on the heart. After vagolysis, quinidine still increased both the atrial and ventricular rates. Following reduction in adrenergic activity by reserpine, hexamethonium, or surgical sympatheetomy, the atrial and ventricular pacemakers were depressed. After sympathetic activity had been reduced by a combination of hexamethonium and reserpine, quinidine caused profound pacemaker depression and sometimes ventricular asystole. Quinidine produced coupling and occasionally runs of ventricular tachycardia independent of the level of sympathetic activity. There was no significant prolongation of the QRS time by quinidine in doses of 5 and 10 mg./Kg. Both the development of ectopic pacemakers and the depression of pacemaker activity of quinidine were dose dependent.
